
Car-T Cell Therapy: Discovery, Design, Trials & Patient Care
Published 9/2025
MP4 | Video: h264, 1280x720 | Audio: AAC, 44.1 KHz, 2 Ch
Language: English | Duration: 1h 15m | Size: 641 MB
Chimeric Antigen Receptor (CAR) T-cell therapy -Molecular designs to clinical application, for students & researchers
What you'll learn
Explain the historical development and biological basis of CAR-T therapy.
Compare and evaluate CAR generations and their clinical performance.
Identify and manage key toxicities and challenges in CAR-T treatment.
Understand emerging synthetic biology and solid tumor strategies.
Requirements
No prior experience is required
Passion for science and basic scientific foundation will ensure you can engage with the material at a deeper level
Description
Are you ready to master one of the most transformative advances in cancer treatment? CAR-T (Chimeric Antigen Receptor T-cell) therapy represents a groundbreaking fusion of immunology, genetic engineering, and clinical oncology-offering hope for patients with otherwise untreatable cancers. This expertly crafted course, "CAR-T Cell Therapy: From Concept to Clinic," provides a comprehensive yet concise exploration of CAR-T technology, tailored specifically for advanced medical students, oncology fellows, PhD researchers, and biotech innovators.In this course, you will embark on a detailed journey starting from the historical origins of immunotherapy to the cutting-edge developments in synthetic biology and next-generation CAR designs. Learn how scientists engineered T cells to recognize and destroy cancer cells, bypassing traditional immune system limitations. Gain a deep understanding of CAR-T cell generations, from first-generation constructs to the sophisticated fifth-generation CARs currently in clinical trials.This course also delivers essential clinical knowledge on the management of CAR-T toxicities such as cytokine release syndrome (CRS) and neurotoxicity (ICANS), equipping you with practical insights used by leading oncologists worldwide. Explore how CAR-T therapies have revolutionized treatment for hematological malignancies like B-cell lymphoma and multiple myeloma, and delve into ongoing research tackling the unique challenges posed by solid tumors.Beyond foundational science, discover the latest advancements, including dual-targeting CARs, armored T cells, synNotch receptor technology, and orthogonal cytokine systems. These innovations represent the future of personalized cancer immunotherapy and open new therapeutic possibilities.Whether you are preparing for a clinical rotation in oncology, pursuing cancer immunology research, or working in biotech R&D, this course gives you a strategic edge by synthesizing complex concepts into digestible modules. In around 60 minutes, you will transform your understanding of cellular immunotherapy, empowering you to contribute meaningfully to this dynamic, life-saving field.Enroll today and join the forefront of cancer immunotherapy education, unlock the science, clinical applications, and future innovations of CAR-T cell therapy.
Who this course is for
Advanced Medical Students & Oncology Fellows seeking real-world clinical context for CAR-T cell therapy.
PhD Researchers in Immunology & Molecular Biology designing next-gen cellular therapies.
Biotech & Pharma Professionals entering the field of cancer immunotherapy.
Academic Faculty & Postdocs needing a compact yet comprehensive CAR-T refresher or curriculum supplement.
You do not have permission to view the full content of this post. Log in or register now.
You do not have permission to view the full content of this post. Log in or register now.